Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Thomas Patrick Kelly. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Thomas Patrick Kelly har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
Chief Financial Officer 0
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Thomas Patrick Kelly. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Thomas Patrick Kelly som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2024-06-11 2024-06-11 4 NA Deciphera Pharmaceuticals, Inc.
Common Stock
U - Other -42.478 0 -100,00
2024-06-11 2024-06-11 4 NA Deciphera Pharmaceuticals, Inc.
Common Stock
D - Sale to Issuer -72.029 42.478 -62,90
2024-06-11 2024-06-11 4 NA Deciphera Pharmaceuticals, Inc.
Common Stock
A - Award 34.157 114.507 42,51
2024-02-20 2024-02-16 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale -3.010 80.350 -3,61 15,62 -47.009 1.254.882
2024-02-20 2024-02-15 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
A - Award 17.275 83.360 26,14
2024-01-18 2024-01-16 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale -2.435 66.085 -3,55 14,47 -35.234 956.237
2023-12-14 2023-12-13 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale -2.792 68.520 -3,92 15,37 -42.905 1.052.954
2023-12-14 2023-12-12 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
A - Award 8.244 71.312 13,07
2023-10-31 2023-10-30 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale -2.316 63.068 -3,54 12,02 -27.833 757.926
2023-10-31 2023-10-28 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
A - Award 8.244 65.384 14,43
2023-06-21 2023-06-16 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale -1.655 57.140 -2,81 14,40 -23.835 822.919
2023-02-17 2023-02-16 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale -1.370 58.795 -2,28 15,10 -20.686 887.746
2023-02-17 2023-02-15 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
A - Award 16.488 60.165 37,75
2023-01-19 2023-01-17 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale -2.403 43.677 -5,21 21,24 -51.043 927.756
2022-06-21 2022-06-16 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale -1.768 46.080 -3,70 10,75 -19.006 495.360
2022-02-18 2022-02-16 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale -1.368 47.848 -2,78 9,05 -12.380 433.024
2022-01-20 2022-01-18 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
A - Award 82.000 82.000
2022-01-20 2022-01-18 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
A - Award 20.500 49.216 71,39
2021-12-17 2021-12-15 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
A - Award 82.265 82.265
2021-12-17 2021-12-15 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
A - Award 11.100 28.716 63,01
2021-02-18 2021-02-16 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
A - Award 49.900 49.900
2021-02-18 2021-02-16 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
A - Award 11.100 17.616 170,35
2021-02-18 2021-02-16 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale -524 6.516 -7,44 48,87 -25.608 318.437
2020-09-16 2020-09-14 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -3.000 47.008 -6,00
2020-09-16 2020-09-14 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale X -3.000 7.040 -29,88 50,01 -150.036 352.085
2020-09-16 2020-09-14 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
M - Exercise 3.000 10.040 42,61 1,89 5.670 18.976
2020-09-10 2020-09-10 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -3.000 50.008 -5,66
2020-09-10 2020-09-10 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale X -3.000 7.040 -29,88 47,71 -143.126 335.869
2020-09-10 2020-09-10 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
M - Exercise 3.000 10.040 42,61 1,89 5.670 18.976
2020-09-10 2020-09-08 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -6.000 53.008 -10,17
2020-09-10 2020-09-08 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale X -1.500 7.040 -17,56 46,55 -69.825 327.710
2020-09-10 2020-09-08 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale X -3.700 8.540 -30,23 45,23 -167.349 386.260
2020-09-10 2020-09-08 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale X -800 12.240 -6,13 44,69 -35.756 547.059
2020-09-10 2020-09-08 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
M - Exercise 6.000 13.040 85,23 1,89 11.340 24.646
2020-05-13 2020-05-11 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -12.000 59.008 -16,90
2020-05-13 2020-05-11 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale X -2.605 7.040 -27,01 55,56 -144.724 391.116
2020-05-13 2020-05-11 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale X -9.395 9.645 -49,34 55,08 -517.516 531.287
2020-05-13 2020-05-11 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
M - Exercise 12.000 19.040 170,45 1,89 22.680 35.986
2020-02-20 2020-02-18 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
A - Award -42.190 42.190 -50,00
2020-02-20 2020-02-18 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
A - Award 7.040 7.040
2020-01-06 2020-01-03 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -4.359 71.008 -5,78
2020-01-06 2020-01-03 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale X -100 0 -100,00 58,74 -5.874
2020-01-06 2020-01-03 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale X -966 100 -90,62 58,14 -56.166 5.814
2020-01-06 2020-01-03 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale X -2.793 1.066 -72,38 57,22 -159.825 61.000
2020-01-06 2020-01-03 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale X -500 3.859 -11,47 56,26 -28.128 217.092
2020-01-06 2020-01-03 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
M - Exercise 4.359 4.359 1,89 8.239 8.239
2020-01-06 2020-01-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -7.641 75.367 -9,21
2020-01-06 2020-01-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale X -100 0 -100,00 62,25 -6.225
2020-01-06 2020-01-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale X -200 100 -66,67 59,48 -11.896 5.948
2020-01-06 2020-01-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale X -1.981 300 -86,85 58,16 -115.219 17.449
2020-01-06 2020-01-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale X -5.360 2.281 -70,15 57,54 -308.408 131.246
2020-01-06 2020-01-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
M - Exercise 7.641 7.641 1,89 14.441 14.441
2019-12-26 2019-12-23 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -40.000 83.008 -32,52
2019-12-26 2019-12-23 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale -40.000 0 -100,00 68,21 -2.728.368
2019-12-26 2019-12-23 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
M - Exercise 40.000 40.000 1,89 75.600 75.600
2019-10-30 2019-10-28 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -3.750 123.008 -2,96
2019-10-30 2019-10-28 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale X -3.750 0 -100,00 40,00 -150.010
2019-10-30 2019-10-28 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
M - Exercise 3.750 3.750 1,89 7.088 7.088
2019-09-13 2019-09-11 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -11.250 126.758 -8,15
2019-09-13 2019-09-11 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale X -3.090 0 -100,00 35,43 -109.468
2019-09-13 2019-09-11 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale X -8.160 8.160 -50,00 34,80 -283.972 283.972
2019-09-13 2019-09-11 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
M - Exercise 11.250 11.250 1,89 21.262 21.262
2019-08-13 2019-08-13 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -11.250 138.008 -7,54
2019-08-13 2019-08-13 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale X -400 0 -100,00 42,92 -17.167
2019-08-13 2019-08-13 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale X -3.586 400 -89,96 42,25 -151.521 16.901
2019-08-13 2019-08-13 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale X -7.264 3.986 -64,57 40,69 -295.568 162.188
2019-08-13 2019-08-13 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
M - Exercise 11.250 11.250 1,89 21.262 21.262
2019-06-21 2019-06-19 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -177 149.258 -0,12
2019-06-21 2019-06-19 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale X -177 0 -100,00 25,00 -4.425
2019-06-21 2019-06-19 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
M - Exercise 177 177 1,89 335 335
2019-06-05 2019-06-03 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -2.100 149.435 -1,39
2019-06-05 2019-06-03 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale X -2.100 0 -100,00 25,20 -52.927
2019-06-05 2019-06-03 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
M - Exercise 2.100 2.100 1,89 3.969 3.969
2019-05-23 2019-05-22 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -100 151.535 -0,07
2019-05-23 2019-05-22 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale X -100 0 -100,00 25,00 -2.500
2019-05-23 2019-05-22 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
M - Exercise 100 100 1,89 189 189
2019-05-23 2019-05-21 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -1.373 151.635 -0,90
2019-05-23 2019-05-21 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale X -1.373 0 -100,00 25,07 -34.419
2019-05-23 2019-05-21 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
M - Exercise 1.373 1.373 1,89 2.595 2.595
2019-05-03 2019-05-01 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -13.500 153.008 -8,11
2019-05-03 2019-05-01 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale X -13.500 0 -100,00 22,93 -309.524
2019-05-03 2019-05-01 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
M - Exercise 13.500 13.500 1,89 25.515 25.515
2019-02-20 2019-02-19 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -1.500 166.508 -0,89
2019-02-20 2019-02-19 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale X -1.500 0 -100,00 30,00 -45.000
2019-02-20 2019-02-19 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
M - Exercise 1.500 1.500 1,89 2.835 2.835
2019-02-01 2019-01-30 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
A - Award 75.000 75.000
2019-01-09 2019-01-07 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -5.000 168.008 -2,89
2019-01-09 2019-01-07 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
S - Sale X -5.000 0 -100,00 25,18 -125.900
2019-01-09 2019-01-07 4 DCPH Deciphera Pharmaceuticals, Inc.
Common Stock
M - Exercise 5.000 5.000 1,89 9.450 9.450
2018-02-20 2018-02-16 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
A - Award 90.000 90.000
2017-10-02 2017-10-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise 103.219 103.219
2017-10-02 2017-10-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -18.269 0 -100,00
2017-10-02 2017-10-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise 5.650 5.650
2017-10-02 2017-10-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -1.000 0 -100,00
2017-10-02 2017-10-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise 38.448 38.448
2017-10-02 2017-10-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -6.805 0 -100,00
2017-10-02 2017-10-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise 173.008 173.008
2017-10-02 2017-10-02 4 DCPH Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
M - Exercise -30.621 0 -100,00
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)